-- In July 2026, the team of DR.WOSSEN, a professional German dermatological skincare brand owned by 28 Wens GmbH, conducted in-depth discussions at its research headquarters, the Global Joint Innovation R&D Center, to hold a special seminar focusing on scientific product innovation and efficacy optimization. This initiative further consolidated the brand’s systematic capabilities in research verification and evidence-based research, and injected new momentum into the continuous iteration of its full range of products.
As a professional dermatological skincare brand originating from Germany, DR.WOSSEN has integrated Germany’s rigorous formulation logic and efficacy-oriented R&D with the demands of the local Chinese market ever since it entered the country. Instead of simply copying its existing overseas models, the brand has developed a localized professional development route for China grounded in regulatory compliance and proven efficacy, supported by long-term research into skin concerns affecting Chinese consumers.
In terms of quality control and regulatory compliance, DR.WOSSEN strictly benchmarks both EU and Chinese cosmetic standards, adhering to science-led skincare and avoiding unnecessary non-functional ingredient combinations. Its interdisciplinary R&D team comprises experts in dermatology, maternal and infant skincare, biology, and other fields, translating cutting-edge German formulation technologies into targeted solutions for problematic skin. Most importantly, the brand fully complies with China's regulatory system. Its core restorative products, including medical dressings and medical repair serums, have obtained Class I Medical Device certifications issued by the National Medical Products Administration (NMPA) of China. These official authoritative qualifications create a differentiated product advantage, offering Chinese consumers truly safe, traceable clinical-grade skincare options.
For sales channels and customer services, DR.WOSSEN carries out localized operations throughout China and has built an integrated online-offline service network. Online, it maintains in-depth cooperation with leading health platforms to form an intelligent service cycle consisting of professional skincare science outreach, digital skin condition evaluation, and targeted product matching. Offline, the brand has steadily established a presence in high-end aesthetic clinics, professional skincare institutions and chain pharmacies, covering a full spectrum of consumer scenarios.
Centered on German scientific skincare concepts, built upon full compliance with Chinese regulatory requirements, and driven by localized innovation, DR.WOSSEN will continue to concentrate on the medical skincare sector. Going forward, the brand will keep developing safer, high-performance skincare products tailored to the skin characteristics of Chinese consumers.
Contact Info:
Name: Liu Yining
Email: Send Email
Organization: 28 Wens GmbH
Website: https://drwossen.com
Release ID: 89199443
Google
RSS